Primary Carnitine deficiency in the Faroe Islands: health and cardiac status in 76 adult patients diagnosed by screening

Abstract Background Carnitine deficiency can cause cardiomyopathy and cardiac arrhythmia. The prevalence in the Faroe Islands is the highest reported in the world (1:300). A nationwide screening program identified 76 Faroese adult patients (15–80 years) with Primary Carnitine Deficiency (PCD). We de...

Full description

Bibliographic Details
Published in:Journal of Inherited Metabolic Disease
Main Authors: Rasmussen, Jan, Køber, Lars, Lund, Allan M., Nielsen, Olav W.
Format: Article in Journal/Newspaper
Language:English
Published: Wiley 2013
Subjects:
Online Access:http://dx.doi.org/10.1007/s10545-013-9640-0
https://onlinelibrary.wiley.com/doi/pdf/10.1007/s10545-013-9640-0
id crwiley:10.1007/s10545-013-9640-0
record_format openpolar
spelling crwiley:10.1007/s10545-013-9640-0 2024-09-15T18:05:36+00:00 Primary Carnitine deficiency in the Faroe Islands: health and cardiac status in 76 adult patients diagnosed by screening Rasmussen, Jan Køber, Lars Lund, Allan M. Nielsen, Olav W. 2013 http://dx.doi.org/10.1007/s10545-013-9640-0 https://onlinelibrary.wiley.com/doi/pdf/10.1007/s10545-013-9640-0 en eng Wiley http://onlinelibrary.wiley.com/termsAndConditions#vor Journal of Inherited Metabolic Disease volume 37, issue 2, page 223-230 ISSN 0141-8955 1573-2665 journal-article 2013 crwiley https://doi.org/10.1007/s10545-013-9640-0 2024-07-04T04:29:59Z Abstract Background Carnitine deficiency can cause cardiomyopathy and cardiac arrhythmia. The prevalence in the Faroe Islands is the highest reported in the world (1:300). A nationwide screening program identified 76 Faroese adult patients (15–80 years) with Primary Carnitine Deficiency (PCD). We describe prior and current health status and symptoms in these patients, especially focusing on cardiac characteristics. Methods Upon identification, patients were immediately admitted for physical examination, ECG, blood tests and initiation of L‐carnitine supplementation. Medical records were reviewed and patients were interviewed. Echocardiography and blood tests were performed in 35 patients before and after L‐carnitine supplementation. Results All patients were either asymptomatic or had minor symptoms when diagnosed. Echocardiography including LVEF, global longitudinal strain and dimensions were normal apart from left ventricular hypertrophy with normal systolic function in one young male. Symptoms, e.g. fatigue, were reported in 43 % with a reduction to 12 % ( p < 0.01) following initiation of L‐carnitine supplementation. Eighty two % reported participation in sports of which 52 % were on a competitive level. ECGs showed limited changes and blood tests were normal. Mean plasma free carnitine increased from 6.1 μmol/L to 15.1 μmol/L ( p < 0.01) within 50 days of L‐carnitine supplementation. Conclusion PCD in adults can cause serious symptoms, but adult Faroese patients identified through a screening program were predominantly asymptomatic with a normal cardiac structure and function. Article in Journal/Newspaper Faroe Islands Wiley Online Library Journal of Inherited Metabolic Disease 37 2 223 230
institution Open Polar
collection Wiley Online Library
op_collection_id crwiley
language English
description Abstract Background Carnitine deficiency can cause cardiomyopathy and cardiac arrhythmia. The prevalence in the Faroe Islands is the highest reported in the world (1:300). A nationwide screening program identified 76 Faroese adult patients (15–80 years) with Primary Carnitine Deficiency (PCD). We describe prior and current health status and symptoms in these patients, especially focusing on cardiac characteristics. Methods Upon identification, patients were immediately admitted for physical examination, ECG, blood tests and initiation of L‐carnitine supplementation. Medical records were reviewed and patients were interviewed. Echocardiography and blood tests were performed in 35 patients before and after L‐carnitine supplementation. Results All patients were either asymptomatic or had minor symptoms when diagnosed. Echocardiography including LVEF, global longitudinal strain and dimensions were normal apart from left ventricular hypertrophy with normal systolic function in one young male. Symptoms, e.g. fatigue, were reported in 43 % with a reduction to 12 % ( p < 0.01) following initiation of L‐carnitine supplementation. Eighty two % reported participation in sports of which 52 % were on a competitive level. ECGs showed limited changes and blood tests were normal. Mean plasma free carnitine increased from 6.1 μmol/L to 15.1 μmol/L ( p < 0.01) within 50 days of L‐carnitine supplementation. Conclusion PCD in adults can cause serious symptoms, but adult Faroese patients identified through a screening program were predominantly asymptomatic with a normal cardiac structure and function.
format Article in Journal/Newspaper
author Rasmussen, Jan
Køber, Lars
Lund, Allan M.
Nielsen, Olav W.
spellingShingle Rasmussen, Jan
Køber, Lars
Lund, Allan M.
Nielsen, Olav W.
Primary Carnitine deficiency in the Faroe Islands: health and cardiac status in 76 adult patients diagnosed by screening
author_facet Rasmussen, Jan
Køber, Lars
Lund, Allan M.
Nielsen, Olav W.
author_sort Rasmussen, Jan
title Primary Carnitine deficiency in the Faroe Islands: health and cardiac status in 76 adult patients diagnosed by screening
title_short Primary Carnitine deficiency in the Faroe Islands: health and cardiac status in 76 adult patients diagnosed by screening
title_full Primary Carnitine deficiency in the Faroe Islands: health and cardiac status in 76 adult patients diagnosed by screening
title_fullStr Primary Carnitine deficiency in the Faroe Islands: health and cardiac status in 76 adult patients diagnosed by screening
title_full_unstemmed Primary Carnitine deficiency in the Faroe Islands: health and cardiac status in 76 adult patients diagnosed by screening
title_sort primary carnitine deficiency in the faroe islands: health and cardiac status in 76 adult patients diagnosed by screening
publisher Wiley
publishDate 2013
url http://dx.doi.org/10.1007/s10545-013-9640-0
https://onlinelibrary.wiley.com/doi/pdf/10.1007/s10545-013-9640-0
genre Faroe Islands
genre_facet Faroe Islands
op_source Journal of Inherited Metabolic Disease
volume 37, issue 2, page 223-230
ISSN 0141-8955 1573-2665
op_rights http://onlinelibrary.wiley.com/termsAndConditions#vor
op_doi https://doi.org/10.1007/s10545-013-9640-0
container_title Journal of Inherited Metabolic Disease
container_volume 37
container_issue 2
container_start_page 223
op_container_end_page 230
_version_ 1810443140845273088